In its observations on South Africa, the UN Committee on the Rights of Persons with Disabilities (UNCRPD) expressed grave concern regarding the rights of people with psychosocial disabilities. Professor Lesley Robertson looks at our medical model of disability and mental health legislation and unpacks the change needed at the societal and health system levels.
Initially hamstrung by low and uncertain supplies of COVID-19 vaccines, government is arguably now in a better position to campaign actively to accelerate vaccine demand, albeit in the midst of an often-harmful viral “infodemic”. Chris Bateman asks what can be done to boost demand for the jab.
Since the enactment of the Choice on Termination of Pregnancy Act (CTOP Act) in 1996, there has been a significant disconnect between the official policy on safe abortion and its implementation. The situation has worsened with the onset of the COVID-19 pandemic and access to abortion services is now severely limited, write Boitumelo Masipa and Thembi Mahlathi.
The new national clinical guidelines for the implementation of the Choice on Termination of Pregnancy Act serve as an opportunity to strengthen services in providing much-needed clarity and guidance to health workers. Marion Stevens and Nozizwe Conco unpack these guidelines on International Safe Abortion Day.
Just 54% of people in South Africa over the age of 50 have received at least one COVID-19 jab, with significant variation between provinces, as experts warn of the possibility of another wave of COVID-19 in future. Chris Bateman reports.
Dr Kenneth Jacobs was elected chairperson of the National Assembly’s Portfolio Committee on Health last month. Biénne Huisman chatted to Jacobs about National Health Insurance, the role of Parliament, working with the Stormers rugby team, and his own background and journey to serving as chair of such an important parliamentary committee.
Already very long waiting times for gender-affirming surgery in South Africa’s public sector have gotten even longer due to the COVID-19 pandemic. Tiyese Jeranji investigates the challenges transgender persons in the country face in accessing gender-affirming care.
Findings of two large phase III clinical trials first presented in 2020 showed a new HIV prevention injection to be highly effective. Yet, experts expect that the injection will only reach clinics in late 2022 or early 2023. If the rhetoric about bringing the urgency of COVID-19 to HIV is to mean anything, these timelines should be made shorter.
The first long COVID study conducted in South Africa found that 82% of patients still had persistent or new symptoms a month after their discharge from hospital. However, much is still unknown about what exactly causes this and how to alleviate the suffering, which is becoming an increasing health burden across the globe. Elsabé Brits surveyed the latest evidence and asked local experts to place it in context.
Globally it is estimated that around one in five to one in ten children and adolescents are affected by mental health disorders. In South Africa, the numbers are highly uncertain, particularly at provincial level, where hardly any data is being gathered. Research suggests that a lack of intersectoral collaboration has resulted in children falling through the cracks – so much so that one expert now says South Africa is completely unable to meet the mental health needs of its children. Tiyese Jeranji investigates.
Little is known about the number of people in South Africa who are living with rare diseases. In fact, there is no recognised definition for rare disease in the country, contributing to inadequate record-keeping and very little data on prevalence, treatment options, and support structures. Laura Owings reports.
An antiretroviral injection administered every two months has been shown to be highly effective in preventing people from getting HIV in two large trials. Catherine Tomlinson asks what needs to happen before these injections become available to people in South Africa.
